Cargando…
Responses to commentary on ‘Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: a systematic review and meta-analysis’ (Int J Surg 2022;106:106929)
Autores principales: | Wang, Zhaoyang, Wang, Yuanyong, Feng, Yingtong, Yan, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389394/ https://www.ncbi.nlm.nih.gov/pubmed/37132181 http://dx.doi.org/10.1097/JS9.0000000000000262 |
Ejemplares similares
-
A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-institutional observational study’ (Int J Surg 2022;106:106842)
por: Huo, Teh-Ia, et al.
Publicado: (2023) -
Commentary on “The Ukrainian refugee crisis and the COVID-19 pandemic in Europe” (Int J Surg 2022;102:106671)
por: Sriwitalai, Won, et al.
Publicado: (2022) -
A commentary on “The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries” (Int J Surg 2022;104:106712)
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
A commentary on ‘Burnout in surgeons: A qualitative investigation into contributors and potential solutions’ (Int J Surg 2022;101:106613)
por: Li, Ziwei, et al.
Publicado: (2023) -
A commentary on “Changes in appendicitis treatment during the COVID-19 pandemic - A systematic review and meta-analysis” (Int J Surg 2021;95:106,148)
por: Chiu, Chong-Chi, et al.
Publicado: (2022)